Does the Red-Hot Weight-Loss Market Make This Pharmaceutical Stock a Buy?
The obesity and diabetes epidemics could be enormous opportunities for these seemingly miracle drugs.
Source: fool.com
Stay updated with breaking news from Estimates Chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The obesity and diabetes epidemics could be enormous opportunities for these seemingly miracle drugs.
Despite a rocky summer for its marketing team, the company is showing some promise.
Despite a rocky summer for its marketing team, the company is showing some promise.
Shares have returned more than 93,000% over their lifetime.
These stocks gained as much as 150% since January. But they could still win big over the coming years.